LimaCorporate Names NuVasive Exec Massimo Calafiore as CEO

LimaCorporate has appointed Massimo Calafiore as its new CEO. Emmanuel Bonhomme, who has been interim CEO for the last five months, will serve in the newly created role of chief commercial officer (CCO).
 
Calafiore was most recently NuVasive’s executive VP and CCO. Prior that he led the company’s product marketing and commercial functions as well as business units NuVasive Specialized Orthopedics and NuVasive Clinical Services.
 
Calafiore has over 20 years of experience in the orthopedic field.
 
“We strongly believe that Massimo is the right person to lead this new phase of our business,” Lars Rasmussen, Chairperson of the LimaCorporate Advisory Board told the press. “He brings extensive industry experience, excellent strategic and leadership skills and a track record of values-based leadership focused on improving patients’ lives. I would like to thank Emmanuel Bonhomme for his dedication as interim CEO and congratulate him on his new role as chief commercial officer.”
 
“I am honored to take on this role as CEO of LimaCorporate,” said Calafiore. “Thanks to our internal talent, know-how, and industry-leading R&D capabilities, I will continue to focus on positioning the company as a global leader in advanced orthopedic solutions. I look forwards to working closely with all the employees and the Leadership Team to continue to serve our surgeons and patients around the globe, as we transform orthopedics, advance patient care, and most importantly, restore the eMotion of Motion in all of our patients.
 
“I also would like to thank Emmanuel for the passion, energy, and enthusiasm he demonstrated in leading LimaCorporate as interim CEO and the Board of Directors for giving me the opportunity to lead the organization during this new phase of growth, helping patients around the world with our innovative products.”